Nicorette Quickmist


Oromucosal spray, solution 1 x 1 dispenser 2 x 1 dispensers
scheduling status
S1
registration number
50/32.16/0547
What Nicorette Quickmist is and what it is used for
Nicorette Quickmist is to be used for the treatment of tobacco dependence in adults by relief of nicotine withdrawal symptoms, including cravings, during a quit attempt. Permanent cessation of tobacco use is the eventual objective. Nicorette Quickmist should preferably be used in conjunction with a behavioural support program.
dosage
Step I: Weeks 1 – 6 Use 1 or 2 sprays when cigarettes normally would have been smoked or if cravings emerge. If after a single spray, cravings are not controlled within a few minutes, a second spray should be used. If 2 sprays are required, future doses may be delivered as 2 consecutive sprays. Most smokers will require 1 – 2 sprays every 30 minutes to 1 hour. Step II: Weeks 7 – 9 Start reducing the number of sprays per day. By the end of week 9 subjects should be using half the average number of sprays per day that was used in Step I. Step III: Weeks 10 – 12 Continue reducing the number of sprays per day so that subjects are not using more than 4 sprays per day during week 12. When subjects have reduced to 2 – 4 sprays per day, oromucosal spray use should be discontinued.
how to take
Posology: Subjects should stop smoking completely during the course of treatment with Nicorette Quickmist. Adults and elderly: The following chart lists the recommended usage schedule for Nicorette Quickmist during full treatment (Step I) and during tapering (Step II and Step III). Up to 4 sprays per hour may be used. Do not exceed 2 sprays per dosing episode and do not exceed 64 sprays (4 sprays per hour, over 16 hours) in any 24-hour period. Paediatric population: Do not administer Nicorette Quickmist to persons under 18 years of age. There is no experience of treating adolescents under the age of 18 with Nicorette Quickmist. Method of administration After priming, point the spray nozzle as close to the open mouth as possible. Press firmly the top of the dispenser and release one spray into the mouth, avoiding the lips. Subjects should not inhale while spraying to avoid getting spray into the respiratory tract. For best results, do not swallow for a few seconds after spraying. Subjects should not eat or drink when administering Nicorette Quickmist. Behavioural therapy advice and support will normally improve the success rate.
What Nicorette Quickmist contains
Each 0,07 mL spray contains 1 mg nicotine Excipients with known effect: Propylene glycol 11 mg/spray, Butylated hydroxytoluene 363 ng/spray. Alcohol (7,1 mg ethanol/spray).
other ingredients
Propylene glycol (E150), anhydrous ethanol, trometamol, poloxamer 407, glycerol (E422), sodium hydrogen carbonate, levomenthol, mint balsamic QL24245, cooler 2 SN046680, sucralose, acesulfame potassium, butylated hydroxytoluene (E321), hydrochloric acid, purified water.
Therapeutic classification
Other.
© 2026 SAHPRA. ALL RIGHTS RESERVED